| 3DLK | B:93-115,B:157-243; A:320-426; B:319-428; B:244-318; A:91-115,A:157-225; A:226-319 | CRYSTAL STRUCTURE OF AN ENGINEERED FORM OF THE HIV-1 REVERSE TRANSCRIPTASE, RT69A |
| 3IG1 | B:99-123,B:165-233; A:226-319; B:234-319; A:320-426; B:320-427; A:91-115,A:157-225 | HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA-THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE |
| 3IRX | B:99-123,B:165-233; A:226-319; B:234-319; A:320-426; B:320-427; A:91-115,A:157-225 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(3,7-DIMETHYL-2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-5-YL)-5-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3-METHYLBENZOTHIOATE. |
| 3IS9 | B:99-123,B:165-233; A:226-319; B:234-319; A:320-426; B:320-427; A:91-115,A:157-225 | CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE RT INHIBITOR DIMETHYL 3,3'-(6-METHOXY-6-OXOHEX-1-ENE-1,1-DIYL)BIS(5-CYANO-6-METHOXYBENZOATE). |
| 3JSM | A:91-115,A:157-225; B:238-319; A:226-319; A:320-426; B:320-428; B:94-115,B:157-237 | K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS-DNA AND COMPLEXED WITH TENOFOVIR-DIPHOSPHATE AS THE INCOMING NUCLEOTIDE SUBSTRATE |
)
)